Explore Cyclo Therapeutics, Inc.'s latest 8-K filing, revealing critical stock and warrant details essential for investors. Get insights on CYTH and CYTHW as of January 10, 2025.
Explore Cyclo Therapeutics, Inc.'s 8-K filing from January 3, 2025, detailing critical corporate events, financial disclosures, and stock information relevant to investors.
Explore Cyclo Therapeutics' 8-K report filed on December 18, 2024, detailing stock and warrants. Learn about their SEC compliance and trading on NASDAQ (CYTH, CYTHW).
Explore Cyclo Therapeutics, Inc.'s latest 8-K report detailing stock and warrant activities as of May 2, 2023. Essential insights for investors and analysts on CYTH and CYTHW.
Discover Cyclo Therapeutics, Inc.'s latest 8-K report filed on October 20, 2023, detailing stock and warrant info for investors. Key data on equity structure and compliance included.
Discover key insights from Cyclo Therapeutics, Inc.'s 8-K report detailing a $2.8M private placement, insider involvement, and equity sale dynamics.
Explore Cyclo Therapeutics, Inc.'s 8-K filing from November 16, 2021, detailing stock info, CIK, and warrants on NASDAQ. Key financial insights included.
Explore Cyclo Therapeutics' 8-K filing dated September 9, 2024, revealing vital details on common stock, warrants, and corporate structure. Stay informed on CYTH!
Discover Cyclo Therapeutics' latest 8-K report from Dec 27, 2023, detailing corporate actions, common stock, and warrants. Stay informed on crucial developments for investors.
Explore Cyclo Therapeutics, Inc.'s 8-K report detailing shareholder voting results on merger and new bylaws. Key corporate strategies unveiled for enhanced operations.
Explore Cyclo Therapeutics, Inc.'s March 2023 8-K report detailing stock info, including par value and ticker symbols CYTH & CYTHW, utilizing XBRL for structured reporting.
Explore Cyclo Therapeutics, Inc.'s December 2023 financial report detailing stock information, warrants, and compliance with SEC regulations. Key insights for investors and stakeholders.